Gadolinium‐enhanced MRI of soft tissue masses

KAREN L. HARKENS, TIMOTHY E. MOORE, WILLIAM T.C. YUH, MARY H. KATHOL, DONALD R. HAWES, GEORGES Y. EL‐KHOURY, KEVIN S. BERBAUM

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The efficacy of gadopentetate dimeglumine (Gd‐DTPA) enhanced magnetic resonance (MR) imaging in the diagnosis and differentiation of soft‐tissue, neoplastic and non‐neoplastic lesion has not been well established. Thirty patients with soft tissue masses (18 neoplastic and 12 non‐neoplastic) were studied, using MR imaging with and without administration of Gd‐DTPA. Gd‐DTPA proved helpful in characterisation of several entities, including differentiation of solid mass from proteinaceous cyst, demonstration of tumour nodules within haemor‐rhagic or necrotic masses, and delineation of tumour adjacent to oedema. The use of Gd‐DTPA may provide additional information for tissue specificity and, in complicated cases, Gd‐DTPA may also provide essential information that cannot be obtained using other methods. We recommend the use of contrast enhanced MR as an adjunct to conventional MR imaging in the initial assessment of musculoskeletal soft tissue masses. However, T2‐weighted images show better tissue contrast of the lesions, and are equal to contrast enhanced images in delineation of tumour margins. Non‐contrast enhanced images are, therefore, probably adequate for the delineation of lesions for surgical planning when a diagnosis has already been made.

Original languageEnglish (US)
Pages (from-to)30-34
Number of pages5
JournalAustralasian Radiology
Volume37
Issue number1
DOIs
StatePublished - Feb 1993

Fingerprint

Magnetic Resonance Imaging
Neoplasms
Gadolinium DTPA
Organ Specificity
Cysts
Edema
Magnetic Resonance Spectroscopy

Keywords

  • Gadolinium
  • Haemorrhage MRI
  • Neoplasm Infection
  • Soft tissue mass

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

HARKENS, KAREN. L., MOORE, TIMOTHY. E., YUH, WILLIAM. T. C., KATHOL, MARY. H., HAWES, DONALD. R., EL‐KHOURY, GEORGES. Y., & BERBAUM, KEVIN. S. (1993). Gadolinium‐enhanced MRI of soft tissue masses. Australasian Radiology, 37(1), 30-34. https://doi.org/10.1111/j.1440-1673.1993.tb00003.x

Gadolinium‐enhanced MRI of soft tissue masses. / HARKENS, KAREN L.; MOORE, TIMOTHY E.; YUH, WILLIAM T.C.; KATHOL, MARY H.; HAWES, DONALD R.; EL‐KHOURY, GEORGES Y.; BERBAUM, KEVIN S.

In: Australasian Radiology, Vol. 37, No. 1, 02.1993, p. 30-34.

Research output: Contribution to journalArticle

HARKENS, KARENL, MOORE, TIMOTHYE, YUH, WILLIAMTC, KATHOL, MARYH, HAWES, DONALDR, EL‐KHOURY, GEORGESY & BERBAUM, KEVINS 1993, 'Gadolinium‐enhanced MRI of soft tissue masses', Australasian Radiology, vol. 37, no. 1, pp. 30-34. https://doi.org/10.1111/j.1440-1673.1993.tb00003.x
HARKENS KARENL, MOORE TIMOTHYE, YUH WILLIAMTC, KATHOL MARYH, HAWES DONALDR, EL‐KHOURY GEORGESY et al. Gadolinium‐enhanced MRI of soft tissue masses. Australasian Radiology. 1993 Feb;37(1):30-34. https://doi.org/10.1111/j.1440-1673.1993.tb00003.x
HARKENS, KAREN L. ; MOORE, TIMOTHY E. ; YUH, WILLIAM T.C. ; KATHOL, MARY H. ; HAWES, DONALD R. ; EL‐KHOURY, GEORGES Y. ; BERBAUM, KEVIN S. / Gadolinium‐enhanced MRI of soft tissue masses. In: Australasian Radiology. 1993 ; Vol. 37, No. 1. pp. 30-34.
@article{1c7e9c118daa415692d65ca9fc319816,
title = "Gadolinium‐enhanced MRI of soft tissue masses",
abstract = "The efficacy of gadopentetate dimeglumine (Gd‐DTPA) enhanced magnetic resonance (MR) imaging in the diagnosis and differentiation of soft‐tissue, neoplastic and non‐neoplastic lesion has not been well established. Thirty patients with soft tissue masses (18 neoplastic and 12 non‐neoplastic) were studied, using MR imaging with and without administration of Gd‐DTPA. Gd‐DTPA proved helpful in characterisation of several entities, including differentiation of solid mass from proteinaceous cyst, demonstration of tumour nodules within haemor‐rhagic or necrotic masses, and delineation of tumour adjacent to oedema. The use of Gd‐DTPA may provide additional information for tissue specificity and, in complicated cases, Gd‐DTPA may also provide essential information that cannot be obtained using other methods. We recommend the use of contrast enhanced MR as an adjunct to conventional MR imaging in the initial assessment of musculoskeletal soft tissue masses. However, T2‐weighted images show better tissue contrast of the lesions, and are equal to contrast enhanced images in delineation of tumour margins. Non‐contrast enhanced images are, therefore, probably adequate for the delineation of lesions for surgical planning when a diagnosis has already been made.",
keywords = "Gadolinium, Haemorrhage MRI, Neoplasm Infection, Soft tissue mass",
author = "HARKENS, {KAREN L.} and MOORE, {TIMOTHY E.} and YUH, {WILLIAM T.C.} and KATHOL, {MARY H.} and HAWES, {DONALD R.} and EL‐KHOURY, {GEORGES Y.} and BERBAUM, {KEVIN S.}",
year = "1993",
month = "2",
doi = "10.1111/j.1440-1673.1993.tb00003.x",
language = "English (US)",
volume = "37",
pages = "30--34",
journal = "Journal of Medical Imaging and Radiation Oncology",
issn = "1754-9477",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Gadolinium‐enhanced MRI of soft tissue masses

AU - HARKENS, KAREN L.

AU - MOORE, TIMOTHY E.

AU - YUH, WILLIAM T.C.

AU - KATHOL, MARY H.

AU - HAWES, DONALD R.

AU - EL‐KHOURY, GEORGES Y.

AU - BERBAUM, KEVIN S.

PY - 1993/2

Y1 - 1993/2

N2 - The efficacy of gadopentetate dimeglumine (Gd‐DTPA) enhanced magnetic resonance (MR) imaging in the diagnosis and differentiation of soft‐tissue, neoplastic and non‐neoplastic lesion has not been well established. Thirty patients with soft tissue masses (18 neoplastic and 12 non‐neoplastic) were studied, using MR imaging with and without administration of Gd‐DTPA. Gd‐DTPA proved helpful in characterisation of several entities, including differentiation of solid mass from proteinaceous cyst, demonstration of tumour nodules within haemor‐rhagic or necrotic masses, and delineation of tumour adjacent to oedema. The use of Gd‐DTPA may provide additional information for tissue specificity and, in complicated cases, Gd‐DTPA may also provide essential information that cannot be obtained using other methods. We recommend the use of contrast enhanced MR as an adjunct to conventional MR imaging in the initial assessment of musculoskeletal soft tissue masses. However, T2‐weighted images show better tissue contrast of the lesions, and are equal to contrast enhanced images in delineation of tumour margins. Non‐contrast enhanced images are, therefore, probably adequate for the delineation of lesions for surgical planning when a diagnosis has already been made.

AB - The efficacy of gadopentetate dimeglumine (Gd‐DTPA) enhanced magnetic resonance (MR) imaging in the diagnosis and differentiation of soft‐tissue, neoplastic and non‐neoplastic lesion has not been well established. Thirty patients with soft tissue masses (18 neoplastic and 12 non‐neoplastic) were studied, using MR imaging with and without administration of Gd‐DTPA. Gd‐DTPA proved helpful in characterisation of several entities, including differentiation of solid mass from proteinaceous cyst, demonstration of tumour nodules within haemor‐rhagic or necrotic masses, and delineation of tumour adjacent to oedema. The use of Gd‐DTPA may provide additional information for tissue specificity and, in complicated cases, Gd‐DTPA may also provide essential information that cannot be obtained using other methods. We recommend the use of contrast enhanced MR as an adjunct to conventional MR imaging in the initial assessment of musculoskeletal soft tissue masses. However, T2‐weighted images show better tissue contrast of the lesions, and are equal to contrast enhanced images in delineation of tumour margins. Non‐contrast enhanced images are, therefore, probably adequate for the delineation of lesions for surgical planning when a diagnosis has already been made.

KW - Gadolinium

KW - Haemorrhage MRI

KW - Neoplasm Infection

KW - Soft tissue mass

UR - http://www.scopus.com/inward/record.url?scp=0027229685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027229685&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1673.1993.tb00003.x

DO - 10.1111/j.1440-1673.1993.tb00003.x

M3 - Article

C2 - 8323507

AN - SCOPUS:0027229685

VL - 37

SP - 30

EP - 34

JO - Journal of Medical Imaging and Radiation Oncology

JF - Journal of Medical Imaging and Radiation Oncology

SN - 1754-9477

IS - 1

ER -